Clinical Trial Update: Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial updating combination chemotherapy for pain in hormone-refractory metastatic prostate cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Pain, Prostate Cancer | Phase 3 | Status: COMPLETED